Metabolically, the deletion of insulin receptor in osteoblasts as represented in the Ob-IR-/- model, results in marked increased in peripheral adiposity accompanied by glucose intolerance, hyperglycemia, hypoinsulinemia, and target tissue insulin resistance caused by reduced undercarboxylated OCN (184, 185). The gene discussed is INSR; the disease is Insulin resistance.